ARE Patent Law Alert:
U.S. Supreme Court Again Grants Certiorari in Myriad to Address the Patent-Eligibility of Human Genes

On November 30, 2012, the U.S. Supreme Court granted certiorari for the second time in Association for Molecular Pathology v. U.S. Patent & Trademark Office, No. 12-368, 2012 U.S. LEXIS 9219 (U.S. Nov. 30, 2012) to address the question: “Are human genes patentable?” The Supreme Court is expected to hear argument and decide the case […]

ARE Patent Law Alert:

PTAB Reverses Examiner’s Obviousness Rejections In Two Related Appeals Where Examiner Did Not Provide An Adequate Rationale For Combining References

On November 30, 2012, the recently formed Patent Trial and Appeals Board (“PTAB”) issued two decisions in appeals in which they reversed the examiner’s obviousness rejections based on the examiner’s failure to satisfy the standard for obviousness articulated by the U.S. Supreme Court in KSR Int’l Co. v. Teleflex, Inc., 550 U.S. 398 (2007). More […]

AIA’s Impact on Multidefendant Patent Litigation: Part 1

Click here to read the article. –  October 19, 2012, IPLaw360, Public Policy and Technology Law360, New York

In the Press: Managing Intellectual Property Turns To Partner Charles R. Macedo For Expertise

Managing Intellectual Property turns to partner Charles R. Macedo for expertise on how the Federal Circuit may handle patent eligibility issues of computer implemented inventions in CLS v. Alice rehearing: How judicial changes will shape the CLS v. Alice Rehearing, 19 Oct 2012, Alli Pryah Read the article here. – Managing Intellectual Property, 19 Oct […]